nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—SLC6A4—chronic obstructive pulmonary disease	0.598	1	CbGaD
Methylphenidate—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0573	0.346	CbGbCtD
Methylphenidate—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0573	0.346	CbGbCtD
Methylphenidate—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0511	0.308	CbGbCtD
Methylphenidate—Dexmethylphenidate—SLC6A4—chronic obstructive pulmonary disease	0.00119	0.611	CrCbGaD
Methylphenidate—Atropine—CYP1A2—chronic obstructive pulmonary disease	0.000759	0.389	CrCbGaD
Methylphenidate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00079	CcSEcCtD
Methylphenidate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.000788	CcSEcCtD
Methylphenidate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000184	0.000788	CcSEcCtD
Methylphenidate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000785	CcSEcCtD
Methylphenidate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000184	0.000785	CcSEcCtD
Methylphenidate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.000784	CcSEcCtD
Methylphenidate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000183	0.000784	CcSEcCtD
Methylphenidate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000183	0.000781	CcSEcCtD
Methylphenidate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.000777	CcSEcCtD
Methylphenidate—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000776	CcSEcCtD
Methylphenidate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000181	0.000775	CcSEcCtD
Methylphenidate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000181	0.000774	CcSEcCtD
Methylphenidate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00018	0.000768	CcSEcCtD
Methylphenidate—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000765	CcSEcCtD
Methylphenidate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.000762	CcSEcCtD
Methylphenidate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.000762	CcSEcCtD
Methylphenidate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000757	CcSEcCtD
Methylphenidate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000753	CcSEcCtD
Methylphenidate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00075	CcSEcCtD
Methylphenidate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00075	CcSEcCtD
Methylphenidate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000747	CcSEcCtD
Methylphenidate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000744	CcSEcCtD
Methylphenidate—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000743	CcSEcCtD
Methylphenidate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00074	CcSEcCtD
Methylphenidate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000172	0.000737	CcSEcCtD
Methylphenidate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000737	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000172	0.000735	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.000735	CcSEcCtD
Methylphenidate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00073	CcSEcCtD
Methylphenidate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00073	CcSEcCtD
Methylphenidate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000726	CcSEcCtD
Methylphenidate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00017	0.000725	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00072	CcSEcCtD
Methylphenidate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000719	CcSEcCtD
Methylphenidate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000719	CcSEcCtD
Methylphenidate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000717	CcSEcCtD
Methylphenidate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000717	CcSEcCtD
Methylphenidate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000715	CcSEcCtD
Methylphenidate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00071	CcSEcCtD
Methylphenidate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00071	CcSEcCtD
Methylphenidate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00071	CcSEcCtD
Methylphenidate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.000707	CcSEcCtD
Methylphenidate—Injury—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000703	CcSEcCtD
Methylphenidate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000164	0.000703	CcSEcCtD
Methylphenidate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.000701	CcSEcCtD
Methylphenidate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000699	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000163	0.000697	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.000697	CcSEcCtD
Methylphenidate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000696	CcSEcCtD
Methylphenidate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000163	0.000696	CcSEcCtD
Methylphenidate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.000696	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000694	CcSEcCtD
Methylphenidate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00069	CcSEcCtD
Methylphenidate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00069	CcSEcCtD
Methylphenidate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00069	CcSEcCtD
Methylphenidate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00069	CcSEcCtD
Methylphenidate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000689	CcSEcCtD
Methylphenidate—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000688	CcSEcCtD
Methylphenidate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000684	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00016	0.000682	CcSEcCtD
Methylphenidate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000681	CcSEcCtD
Methylphenidate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000679	CcSEcCtD
Methylphenidate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000677	CcSEcCtD
Methylphenidate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000676	CcSEcCtD
Methylphenidate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000675	CcSEcCtD
Methylphenidate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000158	0.000674	CcSEcCtD
Methylphenidate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000672	CcSEcCtD
Methylphenidate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000671	CcSEcCtD
Methylphenidate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.000669	CcSEcCtD
Methylphenidate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.000668	CcSEcCtD
Methylphenidate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000666	CcSEcCtD
Methylphenidate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000665	CcSEcCtD
Methylphenidate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000665	CcSEcCtD
Methylphenidate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.000664	CcSEcCtD
Methylphenidate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000662	CcSEcCtD
Methylphenidate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.000661	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00066	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00066	CcSEcCtD
Methylphenidate—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000659	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000658	CcSEcCtD
Methylphenidate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000657	CcSEcCtD
Methylphenidate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000652	CcSEcCtD
Methylphenidate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000652	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000646	CcSEcCtD
Methylphenidate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000641	CcSEcCtD
Methylphenidate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000641	CcSEcCtD
Methylphenidate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000638	CcSEcCtD
Methylphenidate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000638	CcSEcCtD
Methylphenidate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000638	CcSEcCtD
Methylphenidate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000638	CcSEcCtD
Methylphenidate—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000636	CcSEcCtD
Methylphenidate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.000636	CcSEcCtD
Methylphenidate—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000631	CcSEcCtD
Methylphenidate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00063	CcSEcCtD
Methylphenidate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00063	CcSEcCtD
Methylphenidate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.00063	CcSEcCtD
Methylphenidate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000628	CcSEcCtD
Methylphenidate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000628	CcSEcCtD
Methylphenidate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000626	CcSEcCtD
Methylphenidate—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000626	CcSEcCtD
Methylphenidate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000625	CcSEcCtD
Methylphenidate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000625	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000623	CcSEcCtD
Methylphenidate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000618	CcSEcCtD
Methylphenidate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000617	CcSEcCtD
Methylphenidate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000615	CcSEcCtD
Methylphenidate—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000614	CcSEcCtD
Methylphenidate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000612	CcSEcCtD
Methylphenidate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000605	CcSEcCtD
Methylphenidate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000602	CcSEcCtD
Methylphenidate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000602	CcSEcCtD
Methylphenidate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000595	CcSEcCtD
Methylphenidate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000595	CcSEcCtD
Methylphenidate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000594	CcSEcCtD
Methylphenidate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000593	CcSEcCtD
Methylphenidate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000582	CcSEcCtD
Methylphenidate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000579	CcSEcCtD
Methylphenidate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000579	CcSEcCtD
Methylphenidate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000571	CcSEcCtD
Methylphenidate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000571	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00057	CcSEcCtD
Methylphenidate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000567	CcSEcCtD
Methylphenidate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000561	CcSEcCtD
Methylphenidate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000559	CcSEcCtD
Methylphenidate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.000552	CcSEcCtD
Methylphenidate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000129	0.000552	CcSEcCtD
Methylphenidate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00055	CcSEcCtD
Methylphenidate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000548	CcSEcCtD
Methylphenidate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000547	CcSEcCtD
Methylphenidate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000541	CcSEcCtD
Methylphenidate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000539	CcSEcCtD
Methylphenidate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000535	CcSEcCtD
Methylphenidate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000125	0.000534	CcSEcCtD
Methylphenidate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.000534	CcSEcCtD
Methylphenidate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000523	CcSEcCtD
Methylphenidate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000521	CcSEcCtD
Methylphenidate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000514	CcSEcCtD
Methylphenidate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000513	CcSEcCtD
Methylphenidate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000513	CcSEcCtD
Methylphenidate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000509	CcSEcCtD
Methylphenidate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000509	CcSEcCtD
Methylphenidate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000508	CcSEcCtD
Methylphenidate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000508	CcSEcCtD
Methylphenidate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000508	CcSEcCtD
Methylphenidate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000506	CcSEcCtD
Methylphenidate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000506	CcSEcCtD
Methylphenidate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000505	CcSEcCtD
Methylphenidate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000505	CcSEcCtD
Methylphenidate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000504	CcSEcCtD
Methylphenidate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000503	CcSEcCtD
Methylphenidate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000498	CcSEcCtD
Methylphenidate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000498	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000497	CcSEcCtD
Methylphenidate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000496	CcSEcCtD
Methylphenidate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000495	CcSEcCtD
Methylphenidate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000491	CcSEcCtD
Methylphenidate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000489	CcSEcCtD
Methylphenidate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000488	CcSEcCtD
Methylphenidate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000484	CcSEcCtD
Methylphenidate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000483	CcSEcCtD
Methylphenidate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000481	CcSEcCtD
Methylphenidate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00048	CcSEcCtD
Methylphenidate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00048	CcSEcCtD
Methylphenidate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00048	CcSEcCtD
Methylphenidate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000479	CcSEcCtD
Methylphenidate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000479	CcSEcCtD
Methylphenidate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000477	CcSEcCtD
Methylphenidate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000471	CcSEcCtD
Methylphenidate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000469	CcSEcCtD
Methylphenidate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000464	CcSEcCtD
Methylphenidate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000462	CcSEcCtD
Methylphenidate—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000455	CcSEcCtD
Methylphenidate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000453	CcSEcCtD
Methylphenidate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00045	CcSEcCtD
Methylphenidate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000449	CcSEcCtD
Methylphenidate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000447	CcSEcCtD
Methylphenidate—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000445	CcSEcCtD
Methylphenidate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000439	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000437	CcSEcCtD
Methylphenidate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000437	CcSEcCtD
Methylphenidate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00043	CcSEcCtD
Methylphenidate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.98e-05	0.000427	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000422	CcSEcCtD
Methylphenidate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000418	CcSEcCtD
Methylphenidate—Flushing—Prednisone—chronic obstructive pulmonary disease	9.7e-05	0.000415	CcSEcCtD
Methylphenidate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000406	CcSEcCtD
Methylphenidate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000404	CcSEcCtD
Methylphenidate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.34e-05	0.000399	CcSEcCtD
Methylphenidate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.000395	CcSEcCtD
Methylphenidate—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000395	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.18e-05	0.000392	CcSEcCtD
Methylphenidate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.16e-05	0.000392	CcSEcCtD
Methylphenidate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000389	CcSEcCtD
Methylphenidate—Erythema—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000389	CcSEcCtD
Methylphenidate—Pain—Prednisolone—chronic obstructive pulmonary disease	8.74e-05	0.000374	CcSEcCtD
Methylphenidate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000367	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000361	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.42e-05	0.00036	CcSEcCtD
Methylphenidate—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.00036	CcSEcCtD
Methylphenidate—Agitation—Prednisone—chronic obstructive pulmonary disease	8.36e-05	0.000358	CcSEcCtD
Methylphenidate—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000356	CcSEcCtD
Methylphenidate—Malaise—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.000351	CcSEcCtD
Methylphenidate—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.00035	CcSEcCtD
Methylphenidate—Syncope—Prednisone—chronic obstructive pulmonary disease	8.16e-05	0.000349	CcSEcCtD
Methylphenidate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.12e-05	0.000347	CcSEcCtD
Methylphenidate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8e-05	0.000342	CcSEcCtD
Methylphenidate—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000337	CcSEcCtD
Methylphenidate—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000336	CcSEcCtD
Methylphenidate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000331	CcSEcCtD
Methylphenidate—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000331	CcSEcCtD
Methylphenidate—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.00033	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000329	CcSEcCtD
Methylphenidate—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000327	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.53e-05	0.000322	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.43e-05	0.000318	CcSEcCtD
Methylphenidate—Oedema—Prednisone—chronic obstructive pulmonary disease	7.43e-05	0.000318	CcSEcCtD
Methylphenidate—Infection—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000315	CcSEcCtD
Methylphenidate—Shock—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.000312	CcSEcCtD
Methylphenidate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000311	CcSEcCtD
Methylphenidate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.00031	CcSEcCtD
Methylphenidate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.000308	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000307	CcSEcCtD
Methylphenidate—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000303	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000289	CcSEcCtD
Methylphenidate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.76e-05	0.000289	CcSEcCtD
Methylphenidate—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000287	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000285	CcSEcCtD
Methylphenidate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.54e-05	0.00028	CcSEcCtD
Methylphenidate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.000276	CcSEcCtD
Methylphenidate—Rash—Prednisolone—chronic obstructive pulmonary disease	6.45e-05	0.000276	CcSEcCtD
Methylphenidate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000275	CcSEcCtD
Methylphenidate—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000274	CcSEcCtD
Methylphenidate—Headache—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000274	CcSEcCtD
Methylphenidate—Constipation—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000272	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000262	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.00026	CcSEcCtD
Methylphenidate—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.07e-05	0.00026	CcSEcCtD
Methylphenidate—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.000252	CcSEcCtD
Methylphenidate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000251	CcSEcCtD
Methylphenidate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000251	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000234	CcSEcCtD
Methylphenidate—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000228	CcSEcCtD
Methylphenidate—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000225	CcSEcCtD
Methylphenidate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000217	CcSEcCtD
Methylphenidate—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.00021	CcSEcCtD
Methylphenidate—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.72e-05	0.000202	CcSEcCtD
Methylphenidate—Rash—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.0002	CcSEcCtD
Methylphenidate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.0002	CcSEcCtD
Methylphenidate—Headache—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000199	CcSEcCtD
Methylphenidate—Nausea—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000189	CcSEcCtD
